Co-Authors
This is a "connection" page, showing publications co-authored by Robert Goldberg and Matthew Alcusky.
Connection Strength
0.888
-
Toan ATN, Phung TL, Dang TT, Alcusky MJ, Amante DJ, Nguyen HL, Goldberg RJ. Cost-effectiveness of sodium-glucose cotransporter 2 inhibitors in the treatment of chronic kidney disease: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2024 Oct 28; 1-15.
Score: 0.249
-
Chen Q, Baek J, Goldberg R, Tjia J, Lapane K, Alcusky M. To treat or not to treat: a comparative effectiveness analysis of oral anticoagulant outcomes among U.S. nursing home residents with atrial fibrillation. BMC Geriatr. 2024 Jul 19; 24(1):619.
Score: 0.245
-
Chen Q, Baek J, Goldberg R, Tjia J, Lapane K, Alcusky M. Discontinuation of oral anticoagulant use among nursing home residents with atrial fibrillation before hospice enrollment. J Am Geriatr Soc. 2023 10; 71(10):3071-3085.
Score: 0.228
-
Alcusky M, Hume AL, Fisher M, Tjia J, Goldberg RJ, McManus DD, Lapane KL. Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities. Drugs Aging. 2018 12; 35(12):1089-1098.
Score: 0.166